BIOMAT Database Logo BIOMAT Database Logo

Immunohistochemical analysis of collagen expression in human corpora lutea during the menstrual cycle and early pregnancy. 2006

Masaaki Iwahashi, and Yasuteru Muragaki, and Akira Ooshima, and Naohiko Umesaki
Department of Obstetrics and Gynecology, Wakayama Medical University, Wakayama, Japan. masaaki@wakayama-med.ac.jp

OBJECTIVE To investigate the characteristic structure and function of human corpora lutea (CL), various types of collagen expression were determined in the CL tissues during the menstrual cycle and early pregnancy. METHODS In vitro experiment. METHODS Department of obstetrics and gynecology at a medical university. METHODS Regulatory cycling women and pregnant women with ovarian tumor and ectopic pregnancy who underwent adnexectomy. METHODS Immunohistochemistry for human type I, III, and IV collagen with specific monoclonal antibodies was used for analysis. METHODS Expression of type I, III, and IV collagen. RESULTS Immunohistochemical staining for type I and III collagen revealed intense staining of the CL stroma during early pregnancy, as compared with those in the menstrual cycle. Moreover, pericellular intense immunostaining for type IV collagen was observed around the luteal cells, especially luteal granulosa cells, of early pregnancy. CONCLUSIONS These results suggest that alterations in distribution of collagen might play an important role in determining the physiology and structure of the CL during the menstrual cycle and early pregnancy.

UI MeSH Term Description Entries
D008597 Menstrual Cycle The period from onset of one menstrual bleeding (MENSTRUATION) to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase. Endometrial Cycle,Ovarian Cycle,Cycle, Endometrial,Cycle, Menstrual,Cycle, Ovarian,Cycles, Endometrial,Cycles, Menstrual,Cycles, Ovarian,Endometrial Cycles,Menstrual Cycles,Ovarian Cycles
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D003338 Corpus Luteum The yellow body derived from the ruptured OVARIAN FOLLICLE after OVULATION. The process of corpus luteum formation, LUTEINIZATION, is regulated by LUTEINIZING HORMONE. Corpora Lutea,Lutea, Corpora
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

Masaaki Iwahashi, and Yasuteru Muragaki, and Akira Ooshima, and Naohiko Umesaki
Immunohistochemical localization of inhibin subunits in human corpora lutea during menstrual cycle and pregnancy.
September 1991, The Journal of clinical endocrinology and metabolism,
Masaaki Iwahashi, and Yasuteru Muragaki, and Akira Ooshima, and Naohiko Umesaki
Masked gonadotropin-binding sites in human corpora lutea during menstrual cycle and pregnancy.
August 1988, Fertility and sterility,
Masaaki Iwahashi, and Yasuteru Muragaki, and Akira Ooshima, and Naohiko Umesaki
Epidermal growth factor receptors in human corpora lutea during the menstrual cycle and pregnancy.
January 1995, Human reproduction (Oxford, England),
Masaaki Iwahashi, and Yasuteru Muragaki, and Akira Ooshima, and Naohiko Umesaki
Gonadotropin receptors in human corpora lutea of the menstrual cycle and pregnancy.
May 1977, American journal of obstetrics and gynecology,
Masaaki Iwahashi, and Yasuteru Muragaki, and Akira Ooshima, and Naohiko Umesaki
[Studies on luteinizing hormone receptors of human corpora lutea during menstrual cycle and pregnancy].
October 1982, Nihon Sanka Fujinka Gakkai zasshi,
Masaaki Iwahashi, and Yasuteru Muragaki, and Akira Ooshima, and Naohiko Umesaki
Luteinizing hormone receptors in human ovarian follicles and corpora lutea during menstrual cycle and pregnancy.
February 1981, The Journal of clinical endocrinology and metabolism,
Masaaki Iwahashi, and Yasuteru Muragaki, and Akira Ooshima, and Naohiko Umesaki
A differentiation antigen of human large luteal cells in corpora lutea of the menstrual cycle and early pregnancy.
June 1996, Biology of reproduction,
Masaaki Iwahashi, and Yasuteru Muragaki, and Akira Ooshima, and Naohiko Umesaki
Expression of luteinizing hormone and chorionic gonadotropin receptor messenger ribonucleic acid in human corpora lutea during menstrual cycle and pregnancy.
April 1995, The Journal of clinical endocrinology and metabolism,
Masaaki Iwahashi, and Yasuteru Muragaki, and Akira Ooshima, and Naohiko Umesaki
Gonadotropin binding sites in human ovarian follicles and corpora lutea during the menstrual cycle.
May 1987, Obstetrics and gynecology,
Masaaki Iwahashi, and Yasuteru Muragaki, and Akira Ooshima, and Naohiko Umesaki
Luteinizing hormone receptors in human ovarian follicles and corpora lutea during the menstrual cycle.
August 1986, Obstetrics and gynecology,
Copied contents to your clipboard!